ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Epidemiology & Public Health Poster III: Other Rheumatic & Musculoskeletal Diseases (1022–1060)

Date: Monday, November 8, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM
Abstract Number: 1032
Causes of Death Among Populations with Systemic Lupus Erythematosus by Race and Ethnicity
8:30AM-10:30AM
Abstract Number: 1056
Characterization of the Patterns of Care, Access and Direct Costs of Systemic Lupus Erythematosus in Brazil: Findings from the Macunaíma Study
8:30AM-10:30AM
Abstract Number: 1031
Clinical and Humanistic Burden of Dermatomyositis and Polymyositis in the United States: A Systematic Literature Review
8:30AM-10:30AM
Abstract Number: 1045
Composition of Phospholipid Fatty Acids in Erythrocyte Membranes from Patients with Ankylosing Spondylitis
8:30AM-10:30AM
Abstract Number: 1030
Critical Illness in Modern Rheumatology: Analysis of Admissions to Australian and New Zealand ICUs
8:30AM-10:30AM
Abstract Number: 1041
Do Cancer Risks Increased in the Five Major Autoimmune Diseases? A Large Cohort Study in China
8:30AM-10:30AM
Abstract Number: 1050
Epidemiology and Clinical Features of Ophthalmological Manifestations in Behçet’s Disease: Study of 50 Patients of a Series of 120 Patients in a Region in Northern Spain
8:30AM-10:30AM
Abstract Number: 1027
Epidemiology of Latent Tuberculosis Infection in Patients with Rheumatic Immune-mediated Diseases: Single University Study of 1117 Patients
8:30AM-10:30AM
Abstract Number: 1048
Estimating the Weight of Rheumatologic Diseases in Mortality in Spain: Basic Cause of Death vs Multiple Cause Analysis
8:30AM-10:30AM
Abstract Number: 1029
Evaluation of the EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a Population-Based Registry
8:30AM-10:30AM
Abstract Number: 1047
Exposure to Industrial Pollutants and Mortality Due to Inmune-mediated Inflammatory Systemic Diseases (IMD) in Spain
8:30AM-10:30AM
Abstract Number: 1026
Factors Impacting Likelihood of Discontinuing Immunosuppression in Adult Dermatomyositis: A Single-Center Study
8:30AM-10:30AM
Abstract Number: 1052
Female Reproductive Factors and Risk of Joint Replacement Arthroplasty of the Knee and Hip Due to Osteoarthritis in Postmenopausal Women: A Nationwide Cohort Study of 1.36 Million Women
8:30AM-10:30AM
Abstract Number: 1039
Healthcare Resource Utilization and Costs of Dermatomyositis and Polymyositis in the United States: A Systematic Literature Review
8:30AM-10:30AM
Abstract Number: 1055
How to Optimize E-Recruitment Strategies: Lessons Learned from over 3000 Participants in an International Arab Online Study
8:30AM-10:30AM
Abstract Number: 1057
Impact of Osteoarthritis in Younger Adults
8:30AM-10:30AM
Abstract Number: 1022
Incidence of Antisynthetase Syndrome and Risk of Malignancy in a Population-based Cohort (1998-2019)
8:30AM-10:30AM
Abstract Number: 1028
Knee Osteoarthritis and Mortality: The Osteoarthritic Initiative
8:30AM-10:30AM
Abstract Number: 1024
Medical Care Seeking Is Frequent and Associated with Overuse of Low-Value Care for Low Back Pain in Portugal: Results from a Nationwide Population-Based Study
8:30AM-10:30AM
Abstract Number: 1054
Metabolomics as an Innovative Tool for Cardiac Risk Stratification in Patients with Rheumatic Diseases: Results from a Pilot Study
8:30AM-10:30AM
Abstract Number: 1040
Monoclonal Gammopathy in Autoimmune Diseases: Analysis and Follow-up of 160 Cases in a Tertiary Center in China
8:30AM-10:30AM
Abstract Number: 1049
Multimorbidity Differences Between Systemic Lupus Erythematosus Patients and Comparators in Different Age Groups: A Large Nationwide US Study
8:30AM-10:30AM
Abstract Number: 1042
Multimorbidity Prevalence in Systemic Lupus Erythematosus: A Population-Based Study
8:30AM-10:30AM
Abstract Number: 1044
Older Patients with Rheumatic Disease Are Commonly Prescribed Potentially Inappropriate Medications
8:30AM-10:30AM
Abstract Number: 1038
Outcomes of Hydroxychloroquine Screening for Retinopathy in a Cohort of Patients with Rheumatological Conditions
8:30AM-10:30AM
Abstract Number: 1033
Physical Inactivity Among Adults with Specific Chronic Conditions, by Arthritis Status, 49 States and District of Columbia, Behavioral Risk Factor Surveillance System, 2019
8:30AM-10:30AM
Abstract Number: 1043
Prevalence of Multimorbidity in Cutaneous Lupus Erythematosus: A Population-Based Study
8:30AM-10:30AM
Abstract Number: 1023
Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
8:30AM-10:30AM
Abstract Number: 1034
Racial/ethnic Differences in Lupus Pregnancy Outcomes over 1 Decade: A US National Study
8:30AM-10:30AM
Abstract Number: 1046
Risk of Ocular Comorbidities and Blindness Among Patients with Behçet’s Disease: A Nationwide Population-based Cohort Study in Korea
8:30AM-10:30AM
Abstract Number: 1058
Sex-Specific Associations Between Knee Synovial Fluid Biomarkers and Knee Osteoarthritis Pain
8:30AM-10:30AM
Abstract Number: 1025
Survival of Patients with Idiopathic Inflammatory Myopathy in Slovenia
8:30AM-10:30AM
Abstract Number: 1053
Temporal Trends and Geographic Variations of Premature Mortality Related to Musculoskeletal(MSK) and Connective Tissue Disorders in the United States: A 20-Year Analysis from WONDER Database
8:30AM-10:30AM
Abstract Number: 1060
Temporal Trends of Arthropathies Related Mortality in the United States and Its Regional Variations from 1999-2018
8:30AM-10:30AM
Abstract Number: 1059
The Association of Pain and Sleep in Relation to Depressive Symptoms Among Older Adults with Arthritis
8:30AM-10:30AM
Abstract Number: 1036
The Association of Patient Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases
8:30AM-10:30AM
Abstract Number: 1035
The ELSA-Brasil Musculoskeletal Cohort (ELSA-Brasil MSK): Design, Implementation and Prevalence of Chronic Musculoskeletal Pain and Radiographic Knee Osteoarthritis at Baseline
8:30AM-10:30AM
Abstract Number: 1051
Variance of Joint Space Width Across the Tibiofemoral Joint on Knee Radiographs: A Novel Measure of Structure and Progression
8:30AM-10:30AM
Abstract Number: 1037
Variations in Total Knee Replacement Utilization and Outcomes in USA and Canada: The Role of Geography and Socioeconomic Factors

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology